Esperion Therapeutics Inc. (ESPR) Business Metric Overview - Stocknear

Esperion Therapeutics Inc...

NASDAQ: ESPR · Real-Time Price · USD
2.53
0.10 (4.12%)
At close: Sep 04, 2025, 3:59 PM
2.54
0.40%
Pre-market: Sep 05, 2025, 05:00 AM EDT

Esperion Therapeutics Revenue Breakdown

Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Collaboration Revenue Revenue 30.08M 83.08M 20.53M 45.53M 112.98M 11.49M 13.72M 5.49M 7.3M 3.85M 5.02M 5.26M 5.48M 3.21M 3.51M 30.05M 1.63M 1.47M 502K 211.63M 982K
Collaboration Revenue Revenue Growth -63.79% +304.77% -54.92% -59.70% +883.28% -16.24% +149.74% -24.73% +89.51% -23.23% -4.69% -3.99% +70.83% -8.68% -88.31% +1745.76% +10.67% +193.03% -99.76% +21450.61% n/a
Product Revenue 34.91M 59.86M 31.11M 28.3M 24.76M 20.76M 20.25M 20.29M 17.03M 14.97M n/a n/a n/a 12.19M n/a n/a n/a 8.17M n/a n/a 858K
Product Revenue Growth -41.68% +92.45% +9.91% +14.32% +19.25% +2.51% -0.21% +19.15% +13.79% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a

Operating Expense Breakdown

Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015
Selling, General, and Administrative Revenue 39.51M 43M 36.92M 39.98M 44.19M 41.99M 45.42M 33.24M 33.96M 29.9M 24.14M 24.95M 29.61M 30.38M 38.34M 39.27M 46.32M 61.06M 61.55M 48.83M 47.68M 41.55M 21.71M 18.47M 13.49M 12.18M 11.18M 9.01M 6.96M 5.95M 5.26M 5.68M 5.41M 5.03M 4.4M 4.21M 4.63M 5.03M 5.28M 5.67M 5.25M 4.04M
Selling, General, and Administrative Revenue Growth -8.11% +16.44% -7.63% -9.53% +5.23% -7.56% +36.65% -2.12% +13.57% +23.88% -3.27% -15.72% -2.54% -20.75% -2.36% -15.23% -24.15% -0.80% +26.07% +2.40% +14.75% +91.38% +17.57% +36.88% +10.75% +9.00% +24.03% +29.54% +16.83% +13.26% -7.46% +4.97% +7.62% +14.19% +4.51% -9.04% -7.91% -4.68% -6.95% +7.98% +30.19% n/a
Research and Development Revenue 7.24M 12.56M 10.98M 10.4M 11.46M 13.4M 17.74M 14.88M 22.1M 31.38M 33.03M 29.14M 32.43M 24.32M 27.62M 25.33M 25.07M 27.95M 41.96M 35.28M 34.99M 34.7M 38.23M 48.28M 42.79M 46.31M 49.47M 41.55M 39.52M 40.94M 33.44M 40.06M 38.25M 35.86M 24.88M 13.5M 9.7M 9.79M 7.96M 7.25M 7.21M 7.39M
Research and Development Revenue Growth -42.36% +14.39% +5.58% -9.28% -14.49% -24.46% +19.19% -32.64% -29.58% -5.00% +13.35% -10.14% +33.36% -11.94% +9.02% +1.02% -10.30% -33.39% +18.94% +0.85% +0.82% -9.24% -20.81% +12.84% -7.60% -6.40% +19.07% +5.13% -3.46% +22.43% -16.52% +4.73% +6.66% +44.13% +84.33% +39.18% -0.95% +23.06% +9.78% +0.53% -2.45% n/a